262 related articles for article (PubMed ID: 30354235)
1. Transfusion of Platelets Loaded With Recombinant ADAMTS13 (A Disintegrin and Metalloprotease With Thrombospondin Type 1 Repeats-13) Is Efficacious for Inhibiting Arterial Thrombosis Associated With Thrombotic Thrombocytopenic Purpura.
Abdelgawwad MS; Cao W; Zheng L; Kocher NK; Williams LA; Zheng XL
Arterioscler Thromb Vasc Biol; 2018 Nov; 38(11):2731-2743. PubMed ID: 30354235
[TBL] [Abstract][Full Text] [Related]
2. Recombinant ADAMTS13 for Immune Thrombotic Thrombocytopenic Purpura.
Bendapudi PK; Foy BH; Mueller SB; Liu J; Feingold LM; Burke KE; Cruz W; Chen MY; Lau ES; Goldberg RL; Tatake I; Wilkinson SC; Carney BJ; Stone JR; Park D; Avelino AR; Hassan S; Andrzejewski C; Ruby KN; Friedman KD; Brunker PAR; Leaf RK; Higgins J; Dzik WH; Stefely JA; Makar RS
N Engl J Med; 2024 May; 390(18):1690-1698. PubMed ID: 38718359
[TBL] [Abstract][Full Text] [Related]
3. Essential domains of a disintegrin and metalloprotease with thrombospondin type 1 repeats-13 metalloprotease required for modulation of arterial thrombosis.
Xiao J; Jin SY; Xue J; Sorvillo N; Voorberg J; Zheng XL
Arterioscler Thromb Vasc Biol; 2011 Oct; 31(10):2261-9. PubMed ID: 21799176
[TBL] [Abstract][Full Text] [Related]
4. Thrombotic thrombocytopenic purpura: basic pathophysiology and therapeutic strategies.
Crawley JT; Scully MA
Hematology Am Soc Hematol Educ Program; 2013; 2013():292-9. PubMed ID: 24319194
[TBL] [Abstract][Full Text] [Related]
5. Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura.
Sadler JE
Blood; 2008 Jul; 112(1):11-8. PubMed ID: 18574040
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of inhibition of human monoclonal antibodies in immune thrombotic thrombocytopenic purpura.
Halkidis K; Meng C; Liu S; Mayne L; Siegel DL; Zheng XL
Blood; 2023 Jun; 141(24):2993-3005. PubMed ID: 37023370
[TBL] [Abstract][Full Text] [Related]
7. Mechanism underlying severe deficiency of plasma ADAMTS-13 activity in immune thrombotic thrombocytopenic purpura.
Zheng XL
J Thromb Haemost; 2024 May; 22(5):1358-1365. PubMed ID: 38360215
[TBL] [Abstract][Full Text] [Related]
8. Impact of N-glycan mediated shielding of ADAMTS-13 on the binding of pathogenic antibodies in immune thrombotic thrombocytopenic purpura.
Postmus T; Graça NAG; Ferreira de Santana J; Ercig B; Langerhorst P; Luken B; Joly BS; Vanhoorelbeke K; Veyradier A; Coppo P; Voorberg J
J Thromb Haemost; 2023 Dec; 21(12):3402-3413. PubMed ID: 37633643
[TBL] [Abstract][Full Text] [Related]
9. Targeted ADAMTS-13 replacement therapy for thrombotic thrombocytopenic purpura.
Moroniti JJ; Vrbensky JR; Nazy I; Arnold DM
J Thromb Haemost; 2024 Apr; 22(4):896-904. PubMed ID: 38142844
[TBL] [Abstract][Full Text] [Related]
10. ADAMTS13 Biomarkers in Management of Immune Thrombotic Thrombocytopenic Purpura.
Sui J; Zheng L; Zheng XL
Arch Pathol Lab Med; 2023 Aug; 147(8):974-979. PubMed ID: 36223210
[TBL] [Abstract][Full Text] [Related]
11. Plasmin-cleaved von Willebrand factor as a biomarker for microvascular thrombosis.
El Otmani H; Frunt R; Smits S; Barendrecht AD; de Maat S; Fijnheer R; Lenting PJ; Tersteeg C
Blood; 2024 May; 143(20):2089-2098. PubMed ID: 38271661
[TBL] [Abstract][Full Text] [Related]
12. Targeting neutrophil extracellular trap accumulation under flow in patients with immune-mediated thrombotic thrombocytopenic purpura.
Yada N; Zhang Q; Bignotti A; Gralnek SH; Sosnovske D; Hogan K; Ye Z; Zheng L; Zheng XL
Blood Adv; 2024 May; 8(10):2536-2551. PubMed ID: 38513079
[TBL] [Abstract][Full Text] [Related]
13. Thrombotic Thrombocytopenic Purpura: Pathophysiology, Diagnosis, and Management.
Sukumar S; Lämmle B; Cataland SR
J Clin Med; 2021 Feb; 10(3):. PubMed ID: 33540569
[TBL] [Abstract][Full Text] [Related]
14. [Congenital thrombotic thrombocytopenic purpura diagnosed in adulthood after repeated thrombocytopenia since neonatal period].
Yoshino T; Kuriyama T; Utsumi S; Shimakawa T; Minami M; Hayashi M; Matsuo Y; Kokame K; Nakamura E; Matsumoto M; Eto T; Taniguchi S
Rinsho Ketsueki; 2024; 65(3):142-146. PubMed ID: 38569856
[TBL] [Abstract][Full Text] [Related]
15. Structure-function and regulation of ADAMTS-13 protease.
Zheng XL
J Thromb Haemost; 2013 Jun; 11 Suppl 1(0 1):11-23. PubMed ID: 23809107
[TBL] [Abstract][Full Text] [Related]
16. Ticlopidine- and clopidogrel-associated thrombotic thrombocytopenic purpura (TTP): review of clinical, laboratory, epidemiological, and pharmacovigilance findings (1989-2008).
Zakarija A; Kwaan HC; Moake JL; Bandarenko N; Pandey DK; McKoy JM; Yarnold PR; Raisch DW; Winters JL; Raife TJ; Cursio JF; Luu TH; Richey EA; Fisher MJ; Ortel TL; Tallman MS; Zheng XL; Matsumoto M; Fujimura Y; Bennett CL
Kidney Int Suppl; 2009 Feb; (112):S20-4. PubMed ID: 19180126
[TBL] [Abstract][Full Text] [Related]
17. ADAMTS13 autoantibodies cloned from patients with acquired thrombotic thrombocytopenic purpura: 1. Structural and functional characterization in vitro.
Ostertag EM; Kacir S; Thiboutot M; Gulendran G; Zheng XL; Cines DB; Siegel DL
Transfusion; 2016 Jul; 56(7):1763-74. PubMed ID: 27040144
[TBL] [Abstract][Full Text] [Related]
18. A Novel Variant on the Thrombospondin Type-1 Repeat 2 Domain of ADAMTS13 in a Parturient with Suspected Hereditary Thrombotic Thrombocytopenic Purpura and Unusually High ADAMTS13 Activity.
Chen J; Tang N; Wang X; Li J
Semin Thromb Hemost; 2024 Jun; 50(4):654-659. PubMed ID: 37726021
[No Abstract] [Full Text] [Related]
19. Hereditary TTP/Upshaw-Schulman syndrome: the ductus arteriosus controls newborn survival.
Fujimura Y
Int J Hematol; 2024 May; 119(5):532-540. PubMed ID: 38536644
[TBL] [Abstract][Full Text] [Related]
20. Recombinant ADAMTS13 in Congenital Thrombotic Thrombocytopenic Purpura.
Scully M; Antun A; Cataland SR; Coppo P; Dossier C; Biebuyck N; Hassenpflug WA; Kentouche K; Knöbl P; Kremer Hovinga JA; López-Fernández MF; Matsumoto M; Ortel TL; Windyga J; Bhattacharya I; Cronin M; Li H; Mellgård B; Patel M; Patwari P; Xiao S; Zhang P; Wang LT;
N Engl J Med; 2024 May; 390(17):1584-1596. PubMed ID: 38692292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
